TGF-β signaling has recently been shown to participate in dormancy of head and neck squamous cell carcinoma in the bone marrow6 and it is upregulated in DTCs from PCa patients with dormant disease for up to 18 years6. Here, TGFB1 is linked to posterior cortical atrophy.